ZLE:CA:TSX-BMO Low Volatility Emerging Markets Equity ETF (CAD)

ETF | Emerging Markets Equity |

Last Closing

CAD 20.21

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Emerging Markets Equity

Symbol Name Price(Change) Market Cap
XSEM:CA iShares ESG MSCI Emerging Mark..

-0.43 (-1.93%)

CAD 3.24B
XEC:CA iShares Core MSCI Emerging Mar..

-0.24 (-0.78%)

CAD 1.80B
ZEM:CA BMO MSCI Emerging Markets Inde..

-0.23 (-1.00%)

CAD 1.07B
XEM:CA iShares MSCI Emerging Markets ..

-0.23 (-0.66%)

CAD 0.20B
DRFE:CA Desjardins RI Emerging Markets..

+0.29 (+1.23%)

CAD 0.08B
XMM:CA iShares MSCI Min Vol Emerging ..

+0.17 (+0.56%)

CAD 0.06B
RXD:CA RBC Quant Emerging Markets Div..

-0.08 (-0.36%)

CAD 0.04B
VEE:CA Vanguard FTSE Emerging Markets

-0.40 (-1.00%)

N/A

ETFs Containing ZLE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Emerging Markets Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.09% 67% D+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.09% 56% F 71% C-
Trailing 12 Months  
Capital Gain 18.99% 22% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.99% 33% F 45% F
Trailing 5 Years  
Capital Gain -3.30% 11% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.30% 11% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain -3.07% N/A N/A 18% F
Dividend Return -2.55% N/A N/A 15% F
Total Return 0.52% N/A N/A 29% F
Risk Return Profile  
Volatility (Standard Deviation) 9.17% N/A N/A 84% B
Risk Adjusted Return -27.78% N/A N/A 13% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike